Evolent Health Inc reports results for the quarter ended in January - Earnings Summary

Evolent Health

09/08/2024 07:39

* Evolent Health Inc  EVH.N  reported quarterly adjusted
earnings
of 30 cents​​ per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of 14 cents.  The mean expectation of fifteen analysts for the
quarter was for earnings of 25 cents per share. Wall Street
expected results to range from 15 cents to 32 cents per share.
    * Revenue rose 37.9% to $647.15 million from a year ago;
analysts
expected $636.44 million. 
    * Evolent Health Inc's reported EPS for the quarter was a
loss
of 6 cents​.
    * The company reported a quarterly loss of $6.38 million.
    * Evolent Health Inc shares had risen by 9.2% this
quarter and
lost 36.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Evolent Health
Inc is $42.00 
This summary was machine generated from LSEG data August 9 at
06:39 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.25           0.30           Beat
 Mar. 31 2024      0.24           0.34           Beat
 Dec. 31 2023      0.15           0.23           Beat
 Sep. 30 2023      0.07           0.30           Beat